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eEF1A1Because of its extremely limited coding capacity, the hepatitis delta virus (HDV) takes over cellular
machineries for its replication and propagation. Despite the functional importance of host factors in both
HDV biology and pathogenicity, little is known about proteins that associate with its RNA genome. Here, we
report the identiﬁcation of several host proteins interacting with an RNA corresponding to the right terminal
stem–loop domain of HDV genomic RNA, using mass spectrometry on a UV crosslinked ribonucleoprotein
complex, RNA afﬁnity chromatography, and screening of a library of puriﬁed RNA-binding proteins. Co-
immunoprecipitation was used to conﬁrm the interactions of eEF1A1, p54nrb, hnRNP-L, GAPDH and ASF/SF2
with the right terminal stem–loop domain of HDV genomic RNA in vitro, and with both polarities of HDV RNA
within HeLa cells. Our discovery that HDV RNA associates with RNA-processing pathways and translation
machinery during its replication provides new insights into HDV biology and its pathogenicity.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe hepatitis delta virus (HDV) is the smallest known human RNA
pathogen and requires the human hepatitis B virus (HBV) envelope
proteins for virion production and transmission. HDV consists of a
small (∼1680 nucleotides, nt), single-stranded, circular RNAmolecule,
which adopts an unbranched, rod-like structure due to a high degree
of intramolecular complementarity (for a review see Taylor, 2006). Its
genome is proposed to replicate via a double rolling circle mechanism,
in which multiple-length genomic and antigenomic linear transcripts
are processed into unit-length RNAs by intrinsic delta ribozymes.
These linear RNAs are then ligated to produce unit-length circular
molecules. The HDV genome contains a single open reading frame
encoding two viral proteins (HDAgs). These two proteins are mostly
identical in sequence except that the large HDAg (HDAg-L) contains 19
additional amino acids at its C-terminus resulting from post-
transcriptional RNA editing of the termination codon of the small
HDAg (HDAg-S) gene. Each protein has a distinct function: HDAg-S
(195 amino acids) is essential for HDV replication, while HDAg-L (214
amino acids) is necessary for virion assembly, and is reported to be a
dominant negative inhibitor of replication (Taylor, 2006).ll rights reserved.The pathogenicity of HDV is poorly understood, and liver transplanta-
tion remains the only viable option for treatment of advanced HDV liver
disease (Farci, 2003). Notwithstanding its apparent simplicity, HDV
causes a severe, rapidly progressive form of liver disease, which
culminates in chronic liver cirrhosis, and is associated with the
development of hepatocellular carcinoma (Fattovich et al., 2004; Su et
al., 2006; Taylor, 2006; Romeoet al., 2009). The expressionof thehepatitis
delta antigen has been suggested to result in signiﬁcant cytotoxic changes
in HeLa and HepG2 cells (Cole et al., 1991). However, HDV RNA
replication, rather than expression of the delta antigen alone, might be
responsible for cytopathic effects (Wang et al., 2001). Because interaction
of host factors with the HDV RNA genome during viral replication might
adversely affect their normal cellular activities, identiﬁcation of these
factors is required to understand HDV pathogenicity.
Many studies using cultured cells and cell extracts have implicated
RNAP II in HDV replication (Filipovska and Konarska, 2000; Moraleda
and Taylor, 2001; Greco-Stewart et al., 2007; Abrahem and Pelchat,
2008; Chang et al., 2008). It has also been hypothesized that RNAP I, or
an RNAP I-like polymerase, might be involved in HDV replication
because some antigenomic HDV RNA has been observed in the
nucleolus; HDV RNA synthesis was reported to be associated with the
RNAP I-speciﬁc transcription factor SL1; and HDV RNA accumulation
was resistant to a higher dose of the RNAP II inhibitor α-amanitin
(Modahl et al., 2000; Macnaughton et al., 2002; Li et al., 2006).
Recently, we further implicated RNAP I in HDV replication and also
Fig. 1. Schematic representation of the HDV RNA genome and secondary structure of the right terminal region of the genomic polarity (R199G). R199G RNA fragment was in vitro-
synthesized and used as bait in the identiﬁcation of HDV RNA-interacting proteins. The proposed initiation site for HDAgmRNA transcription and the region binding both RNAP II and
PSF are indicated (Gudima et al., 2000; Greco-Stewart et al., 2006; Abrahem and Pelchat, 2008).
Fig. 2. Detection of a speciﬁc UV crosslinked complex between R199G and HeLa nuclear
extract proteins. Radiolabelled R199G was incubated with HeLa NE and subjected to UV
irradiation at a wavelength of 365 nm. Complexes were resolved on SDS-PAGE.
Speciﬁcity of the interaction was veriﬁed by addition of 50× molar excess of either a
speciﬁc (R199G) or non-speciﬁc (P11.60) RNA competitor. The asterisk indicates the
excised complex.
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association of both RNAP I and RNAP III with the HDV RNA genome
(Greco-Stewart et al., 2009). Another enzyme involved in the life cycle
of HDV is the adenosine deaminase that acts on RNA (ADAR)-1,
believed to catalyze the editing reaction that leads to the production of
the large delta antigen (Wong and Lazinski, 2002). Other cellular
proteins reported to interact with HDV RNA include the cellular
double-stranded RNA-dependent protein kinase (Circle et al., 1997),
the negative elongation factor (Yamaguchi et al., 2002), glyceralde-
hyde 3-phosphate dehydrogenase (Lin et al., 2000), and the
polypyrimidine tract-binding (PTB) protein-associated splicing factor
(PSF; Greco-Stewart et al., 2006). Finally, HDV RNA was shown to
interact with the splicing factor SC35, and to transiently co-localize
with it in nuclear speckles (Bichko and Taylor, 1996; Abrahem and
Pelchat, 2008).
In this study, we used several experimental approaches to identify
nuclear proteins that associate with the HDV RNA genome, speciﬁcally
with an HDV-derived RNA that we and others have reported to act as
an RNA promoter in vitro (Beard et al., 1996; Greco-Stewart et al.,
2007; Abrahem and Pelchat, 2008). Firstly, we revisited the mass
spectrometry analysis of a ribonucleoprotein complex produced by UV
crosslinking of the HDV-derived RNA fragment with HeLa nuclear
extract (NE; Greco-Stewart et al., 2006). Secondly, we used an RNA
afﬁnity puriﬁcation strategy followed by mass spectrometric analysis.
Finally, we performed electrophoretic mobility shift assays (EMSAs)
using a number of puriﬁed RNA-binding proteins. Using these
approaches, we identiﬁed four new HDV-interacting cellular proteins
(eEF1A1, p54nrb, hnRNP-L, and ASF/SF2) and corroborated a pre-
viously known interaction (GAPDH). Together, this information
increases our knowledge of HDV biology and serves as a foundation
to study HDV pathogenicity.
Results
Identiﬁcation of HeLa NE proteins involved in the formation of a UV
crosslinked complex with the right terminal stem–loop domain of HDV
genomic RNA
To identify human proteins that interact with the HDV RNA
genome, and thusmight be important for HDV biology, we used as bait
a 199-nt HDV-derived RNA fragment corresponding to what we refer
to as the right terminal stem–loop domain of the genomic polarity
(R199G; Fig. 1). We selected this RNA segment because it contains the
proposed initiation site for HDAg mRNA transcription (Gudima et al.,
2000); it was shown to direct synthesis of antigenomic RNA in an in
vitro transcription reaction (Beard et al., 1996; Abrahem and Pelchat,
2008); and we have reported the speciﬁc binding of RNAP II to R199G
(Greco-Stewart et al., 2007; Abrahem and Pelchat, 2008). All these
features suggest that this part of the HDV genome includes an RNApromoter for RNAP II, which might be involved in viral replication
and/or transcription.
Recently, we reported the formation of a single, high molecular
weight ribonucleoprotein complex following UV crosslinking of HeLa
NE proteins to R199G (Greco-Stewart et al., 2006). Although
preliminary mass spectrometry analysis of this complex led to the
identiﬁcation of PSF as a novel HDV RNA-interacting protein (Greco-
Stewart et al., 2006), the presence of other proteins in the complex
was likely. To identify additional proteins binding to R199G, we
revisited the crosslinking experiment. R199G was synthesized in
vitro in the presence of [α-32P] GTP, incubated with HeLa NE
proteins, and the ribonucleoprotein complexes were UV crosslinked
at 365 nm. Following UV irradiation, the mixtures were fractionated
by SDS-PAGE and the complex was detected by autoradiography. In
agreement with our previous report (Greco-Stewart et al., 2006), a
speciﬁc band migrating as a species of approximately 220 kDa was
detected when the radiolabelled R199G was incubated with HeLa NE
proteins and UV crosslinked (Fig. 2). To test the speciﬁcity of the
complex, we challenged its formation with P11.60, which is a small
RNA species that folds into a hairpin (Pelchat and Perreault, 2004),
thus providing an excellent competitive RNA to test for non-speciﬁc
Table 1
Proteins identiﬁed by LC-MS/MS following analysis of a ribonucleoprotein complex obtained from a UV crosslinking experiment between HDV-derived RNA (R199G) and HeLa
nuclear extract proteins.
Protein identiﬁed Biological function Accession no. Peptides
identiﬁed
MW (kDa)
Eukaryotic translation elongation factor 1A1 Translation 4503471 4 50
Polypyrimidine tract-binding protein-associated splicing factor (PSF) Pre-mRNA processing 33879558 3 75
Nuclear mitotic apparatus protein 1 Mitotic spindle stabilization 71361682 3 238
p54nrb Pre-mRNA processing 543010 2 54
F-box and leucine-rich repeat protein 17 Protein–ubiquitin ligase complex 45238580 2 34
ANKS6 protein Unknown function 39963545 2 50
DNA-directed RNA polymerase II polypeptide A Transcription 4505939 2 217
Kalirin/RhoGEF kinase isoform 3 Guanine nucleotide exchange factor 68362740 2 144
Fig. 3. Interaction of hnRNP-L with R199G RNA. RNA-coupled beads were incubated
with HeLa nuclear extract. The bound proteins were eluted with SDS loading dye and
resolved by SDS-PAGE. The gel was silver-stained and the band corresponding to a
protein of approximately 55 kDa (asterisk), and absent from the negative control, was
excised and identiﬁed by mass spectrometry as hnRNP-L.
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secondary structures. Challenges of the complex with a molecular
excess of this non-speciﬁc competitor did not signiﬁcantly alter its
formation. However, complex formation was greatly reduced by the
addition of excess of non-radiolabelled R199G RNA, and no complex
was observed in the absence of NE or UV irradiation. Taken together,
these observations demonstrate that NE protein(s) interact speciﬁ-
cally with R199G.
The complexes from three independent experiments were excised
and analyzed by mass spectrometry (LC-MSMS, Wemb Biochem), as
previously described (Greco-Stewart et al., 2006). As a negative
control, UV irradiationwas performed on samples without R199G and
subjected to the same treatment. The protonated masses of those
peptides were then used to search humanprotein sequence databases.
To be cautious, only the proteins for which at least two peptides were
identiﬁed in the three samples, andwhich were not found the absence
of R199G, were considered. A list of the putative HDV-interacting
proteins is presented in Table 1. In accordance with our previous
reports (Greco-Stewart et al., 2006; Greco-Stewart et al., 2007;
Abrahem and Pelchat, 2008), peptides corresponding to both the
largest subunit of RNAP II and PSF were detected as constituents of the
complex. In addition, numerous peptides corresponding to proteins
involved in a wide range of cellular processes were detected in the
sample containing R199G, suggesting their interaction with the right
terminal stem–loop region of genomic HDV RNA. Among those were
peptides speciﬁc to the mRNA splicing factor p54nrb, the eukaryotic
translation elongation factor 1 alpha 1 (eEF1A1), the F-box and
leucine-rich repeat protein 17, the isoform 3 of kalirin/RhoGEF kinase,
and the nuclear mitotic apparatus protein 1.
Puriﬁcation of the splicing factor hnRNP-L using R199G
afﬁnity chromatography
As an alternative to the UV crosslinking approach, we used an RNA
afﬁnity chromatography puriﬁcation procedure that involves chemical
crosslinking of R199G to adipic acid dehydrazide agarose beads (Vioque
and Altman, 1986). R199G was synthesized in vitro and oxidized prior
to being covalently linked to the beads. Nucleic acid-coupled beads
were then incubated with pre-cleared HeLa NE. To assess the speciﬁcity
of the complexes, an excess amount of yeast total tRNA was added to
the extract. In addition, uncoupled adipic acid dehydrazide agarose
beads were tested for protein interaction to rule out non-speciﬁc
binding of NE proteins to the beads. Following incubation and washing
to remove unbound proteins, the proteins were eluted with SDS
loading dye and resolved on SDS-PAGE. Silver staining of the gel
revealed a band corresponding to a protein of approximately 55 kDa
(Fig. 3). This band was clearly absent from the negative control, which
consisted of uncoupled beads. The band was excised from the gel, in-
gel trypsin digested, and analyzed by mass spectrometry (LC-MSMS;
Wemb Biochem). By searching human protein sequence databases,
peptides matching the heterogeneous nuclear ribonucleoprotein L
(60 kDa; hnRNP-L) were detected in the sample.Identiﬁcation of the alternative splicing factor ASF/SF2 as a R199G
binding protein by screening a library of proteins
HDV RNAwas previously found to associate with the splicing factor
SC35 and to co-localize with it in nuclear speckles (Bichko and Taylor,
1996; Abrahem and Pelchat, 2008). Our experiments led to the
identiﬁcation of three other pre-mRNA splicing factors as potential
R199G-interacting partners, namely p54nrb, hnRNP-L, and PSF
(recently reported to interact speciﬁcally and directly with HDV
RNA; Greco-Stewart et al., 2006). Accordingly, several puriﬁed
recombinant proteins known to be involved in RNA metabolism,
speciﬁcally during splicing events, were screened for their interaction
with R199G by EMSA (Fig. 4). We tested the Sm proteins B/B’ and D1,
which are ribonucleoproteins that collectively make up the Sm core of
snRNPs (small nuclear ribonucleoproteins); the serine/arginine (SR)-
rich proteins ASF/SF2 and SRp30, which play essential roles in
constitutive as well as regulated splicing (Hastings and Krainer, 2001);
Sam68, a member of the signal transduction and activation of RNA
(STAR) family of proteins implicated in alternative splicing (Hartmann
et al., 1999); and the Tudor domain, which is found in several splicing
factors and RNA-binding proteins (Ponting, 1997).
Radiolabelled R199G was synthesized in vitro and was allowed to
bind to the puriﬁed recombinant proteins. To ensure speciﬁcity of the
interactions, the samples were incubated either in the presence or
absence of poly(A), a non-speciﬁc competitor. Following a 30-minute
incubation at 4 °C, the samples were subjected to electrophoresis
through a non-denaturing 5% polyacrylamide gel. Under our condi-
tions, retardation of the migration of R199G was observed with ASF/
SF2, both in the presence and absence of molecular excess of poly(A),
Fig. 5. Interaction of R199G with various nuclear factors in HeLa nuclear extract.
Radiolabelled R199G RNA was co-immunoprecipitated with each eEF1A1, p54nrb,
hnRNP-L, GAPDH, ASF/SF2 and SMN fromHeLa nuclear extract using the corresponding
antibody. Speciﬁcity of the interaction was veriﬁed by addition of 50× molar excess of
either a speciﬁc (R199G) or non-speciﬁc (P11.60) RNA competitor.
Fig. 4. Direct interaction of R199G with GST-ASF/SF2 in vitro. Electrophoretic gel shift
assays (EMSAs) were performed to analyze interaction of the genomic HDV RNA
promoter with several recombinant human proteins. Radiolabelled R199G was
incubated with each protein in the presence or absence of poly(A) (100 ng).
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derived RNA molecule. Similar experiments showed that ASF/SF2
does not bind to P11.60 (data not shown), conﬁrming that the binding
of ASF/SF2 to R199G was not due to non-speciﬁc afﬁnity to double-
stranded RNA or stem–loop secondary structures. Finally, we observed
an apparent shift of the radiolabelled R199G in the presence of SmB.
However, because the RNA was trapped in the wells of the gel, this
ﬁnding was considered inconclusive. No apparent binding of R199G to
the other proteins was observed, although activity of these proteins
was not tested.
Interaction of p54nrb, eEF1A1, GAPDH, hnRNP-L, and ASF/SF2 with R199G
in HeLa NE
To conﬁrm the interactions between R199G and the newly
identiﬁed R199G-interacting proteins, co-immunoprecipitation
experiments were performed with R199G and nuclear extract
proteins. Because our analysis was limited to commercial availability
of antibodies, only p54nrb, eEF1A1, hnRNP-L, and ASF/SF2 were
analyzed. We also included GAPDH in our analysis, based on previous
ﬁndings indicating GAPDH association with the opposite extremity of
the HDV genome (Lin et al., 2000), which also interacts with RNAP II
(Filipovska and Konarska, 2000; Greco-Stewart et al., 2007). Radi-
olabelled R199Gwas incubated with HeLa NE proteins in the presence
or absence of molecular excess of P11.60 or unlabelled R199G, to verify
the speciﬁcity of the interaction. Following co-immunoprecipitation
using speciﬁc antibodies against those ﬁve proteins, the resulting
mixture was resolved on denaturing PAGE and visualized by
autoradiography (Fig. 5).
R199G co-immunoprecipitated with p54nrb, eEF1A1, GAPDH,
hnRNP-L, and ASF/SF2. The presence of molecular excess of the
non-speciﬁc competitor P11.60 did not signiﬁcantly alter the amount
of R199G that was co-immunoprecipitated. However, the interactions
were greatly reduced by the addition of molecular excess of non-
radiolabelled R199G RNA, and no R199G RNA was detected in the
absence of nuclear extract. Finally, no R199G was co-immunopreci-
pitated using an anti-IgG antibody (data not shown), or an antibody
speciﬁc for SMN (Fig. 5), a protein containing a Tudor domain, which
has shown no interaction with HDV RNA by EMSA (Fig. 4). Taken
together, our observations demonstrate that these proteins interact
speciﬁcally with R199G within HeLa NE.
Interaction of p54nrb, eEF1A1, GAPDH, hnRNP-L, and ASF/SF2 with both
polarities of HDV RNA in HeLa cells replicating HDV RNA
To establish the signiﬁcance of these interactions in a physiological
context, HeLa cells replicating HDV RNA were subjected to aribonucleoprotein immunoprecipitation assay (RIPA; Niranjanakumari
et al., 2002). This technique is both sensitive and speciﬁc, and has
recently been employed by our laboratory to substantiate cellular
interactions of both PSF and RNAP II with HDV RNA (Greco-Stewart et
al., 2006; Greco-Stewart et al., 2007).
HeLa cells were transfected with both a dimeric HDV transcript of
genomic polarity and a plasmid transiently expressing HDAg-S from a
CMV promoter; HDAg-S is required to initiate HDV RNA replication
(Kuo et al., 1989). Four days post-transfection, the cells were treated
with formaldehyde, a reversible crosslinking agent. Following cell lysis
and co-immunoprecipitations of the RNA–protein complexes using
speciﬁc antibodies, the crosslinks were heat-reversed. The RNA was
isolated and analyzed by RT-PCR for the HDV RNA genome (Fig. 6).
Bands corresponding to the R199 cDNA (i.e. 232 bp) were detected
when the crosslinked extract was subjected to co-immunoprecipita-
tion with antibodies against p54nrb, eEF1A1, GAPDH, hnRNP-L, and
ASF/SF2. R199 cDNAwas not detected in the absence of antibody, or in
the presence of anti-IgG antibody, indicating that the RT-PCR products
obtained were not the results of non-speciﬁc binding of HDV RNA to
either the antibody or the protein G agarose beads. Furthermore, no
HDV RNA–protein complexes were recovered from non-crosslinked
HeLa lysates. However, in the case of eEF1A1 and ASF/SF2, a small
amount of PCR product was recovered after the ampliﬁcation
reactions, which might indicate strong associations of these proteins
with HDV RNA. Taken together, these data indicate the speciﬁc
interactions of these proteins with HDV RNA within HeLa cells.
Additionally, the primers used for the reverse transcription
reactions were designed to distinguish between the polarities of
HDV RNA. For instance, the antisense primer used to generate the
R199G cDNA was only able to reverse transcribe from the genomic
polarity of HDV RNA (Fig. 6, HDVG RNA lanes). Because RNA fragments
corresponding to both polarities of HDV were detected when the
crosslinked extract was co-immunoprecipitated with speciﬁc anti-
bodies against p54nrb, eEF1A1, GAPDH, hnRNP-L, and ASF/SF2, we
conclude that these proteins associate with both polarities of HDV
RNA within HeLa cells. These data indicate that each polarity of the
Fig. 6. Interaction ofHDVRNAwith various cellular factors in culturedHeLa cells. Ribonucleoprotein immunoprecipitation assayswere performed to conﬁrm the interaction ofHDVRNAof
both genomic and antigenomic polarity (G or AG) with the candidate host proteins in HDV infected HeLa cells. HDV RNA was co-immunoprecipitated from lysates of formaldehyde
crosslinkedHDV-replicating cells with the indicated proteins using the corresponding antibodies. HDV RNAwas detected by reverse transcription using strand-speciﬁc primers to produce
R199 cDNA. Co-immunoprecipitations from non-crosslinked cell lysates serve as speciﬁcity controls. HDVG RNA lanes are controls using in vitro transcribed HDV RNA of genomic polarity.
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and that these interactions occur in a cellular context during HDV
replication.
Discussion
HDV is unique among human viral pathogens in that it has a very
limited coding capacity, and thus must rely on host factors for its
replication. In addition, because the HDV RNA genome interacts with
several host proteins, it is likely that these interactions affect normal
host functions. Despite their functional importance in both viral
replication and pathogenicity, only a few cellular proteins have been
reported to interact with HDV RNA. Accordingly, this study was
undertaken to identify additional host factors that interact speciﬁcally
with HDV RNA, and thatmight be involved in HDV transcription and/or
replication. We used an HDV RNA fragment corresponding to the right
stem–loop domain of the genomic polarity that has been suggested to
include an RNA promoter for RNAP II, with a role in viral replication
and/or transcription of the HDAg mRNA (Beard et al., 1996; Gudima
et al., 2000; Greco-Stewart et al., 2007; Abrahem and Pelchat, 2008).
Using a UV crosslinking approach and RNA afﬁnity chromatography,
we have identiﬁed several HDV RNA-interacting partners. As reported
previously (Greco-Stewart et al., 2006), UV crosslinking of HeLa NE to
R199G did not yield complexes corresponding to the molecular weight
of the individual proteins. It is likely that several of these proteins
might have crosslinked to R199G simultaneously, which would
account for the detection of a single high molecular weight complex.
Because a number of these proteins are known to be involved in
splicing events, we screened additional puriﬁed splicing factors in
EMSAs. The interactions between HDV RNA and these proteins were
further validated by co-immunoprecipitation both in vitro and in HeLa
cells replicating HDV RNA. In addition to PSF and RNAP II (Greco-Stewart et al., 2006; Greco-Stewart et al., 2007; Abrahem and Pelchat,
2008), our results demonstrate the interactions of eEF1A1, p54nrb,
hnRNP-L, GAPDH and ASF/SF2 with HDV RNA. Interestingly, we
identiﬁed different proteins using these various experimental
approaches, suggesting that those proteins might represent only a
small subset of the host proteins interacting with HDV RNA. On the
other hand, we might have been too cautious in our analysis of the
mass spectrometry results, as single peptides for both hnRNP-L and
ASF/SF2 were also detected in some of the crosslinked complexes.
The identiﬁed proteins are frequently linked to viral replication
and/or transcription. ASF/SF2 belongs to the family of SR (serine
arginine-rich) proteins and promotes exon inclusion by recognizing
and binding to exonic splicing enhancers (ESEs), and this binding is
suggested to be modulated by the C-terminal domain (CTD) of the
largest subunit of RNAP II (McCracken et al., 1997; Cramer et al., 1999).
P54nrb is related to PSF (Dong et al., 1993), which we previously
reported to interact speciﬁcally and directly with HDV RNA domains
also bound by RNAP II (Greco-Stewart et al., 2006; Greco-Stewart
et al., 2007). PSF forms a heterotetramer with p54nrb, and together
they were shown to interact with the CTD of RNAP II (Emili et al.,
2002). HnRNP-L belongs to a family of abundant nuclear proteins
frequently linked to viral replication (for a review see Lai, 1998).
GAPDH has been shown to greatly stimulate transcription by RNAP II
in Xenopus laevis oocytes (Morgenegg et al., 1986) and has been
reported to associate with RNA polymerase II in Schizosaccharomyces
pombe through a direct interaction with the Rpb7 subunit of RNAPII
(Mitsuzawa et al., 2005). GAPDH was also reported to be involved in
RNA-dependent viral RNA synthesis, by binding to either the 5′-UTR
(+) of the hepatitis A virus or the 3′-UTR (+/−) of the human
parainﬂuenza virus-3 (De et al., 1996; Schultz et al., 1996). The
translation factor eEF1A1 was reported to be involved in viral RNA
synthesis, by associating with the RNA-dependent RNA polymerase
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(Das et al., 1998), turnip yellow mosaic virus (Joshi et al., 1986) and
West Nile virus (Blackwell and Brinton, 1997). Thus, it is tempting to
speculate that these proteins might function to enhance the RNAP II-
mediated replication of HDV RNA.
It is also possible that some of these proteins are involved in HDV
RNA intracellular shuttling. For instance, PSF, p54nrb, and eEF1A have
been identiﬁed as constituents of an RNA-transporting granule in the
mouse brain (Kanai et al., 2004). Furthermore, hnRNP-L binds to the
pre-mRNA processing enhancer (PPE) of the herpes simplex virus
thymidine kinase intronless mRNA, and enhances its cytoplasmic
export (Liu and Mertz, 1995). Some SR proteins have also been shown
to enhance cytoplasmic accumulation of an intronless mRNA by
interacting with a cis-acting RNA element (Huang and Steitz, 2001).
The functions of these proteins with respect to HDV might be related
to their ability to bind and export intronless mRNAs, since HDV RNA
itself is intronless.
The high accumulation of HDV RNA in infected cells (Chen et al.,
1986) suggests that the interaction of HDV RNA with these factors
might interferewith several of their normal cellular functions, thereby
eliciting the virus' pathogenic effect. For instance, it is possible that
HDV alters ASF/SF2, PSF, p54nrb and/or hnRNP-L-mediated alternative
splicing, since deregulated splicing has been associated with many
types of cancer (Castiglioni et al., 2006; Lee et al., 2006; Pospisil et al.,
2006), and HDV is known to be associated with liver cancer (Fattovich
et al., 2004; Su et al., 2006; Romeo et al., 2009). ASF/SF2 has also been
shown to play a signiﬁcant role in protecting chromosomal DNA from
the damaging effects of R-loops that form between nascent RNA
transcripts and template DNA; inactivation of this protein leads to
genomic instability (Li andManley, 2005; Li et al., 2005). PSF represses
the expression of numerous oncogenes (Song et al., 2004). The
interaction of PSF with HDV RNA might reverse this repression and
promote metastasis (Song et al., 2002; Song et al., 2004; Song et al.,
2005). eEF1A1 has been shown to bind the non-coding RNA HSR1 and
to activate the heat shock transcription factor 1 (HSF1), which induces
the expression of heat shock proteins. Interestingly, Hsp105 was
reported to be downregulated in Huh7 cells transiently transfected
with a plasmid encoding genomic HDV RNA (Mota et al., 2008). It is
possible that HDV RNA might compete with HSR1 for eEF1A binding,
thereby impeding a heat shock response. GAPDH has been proposed to
play an essential role in apoptosis (Ishitani and Chuang, 1996; Ishitani
et al., 1998; Fukuhara et al., 2001; Barbini et al., 2007). The potential
deregulation of this important process by HDV might also contribute
to liver disease. Although these proteins are very abundant, their
essential nature suggests that interfering with their ability to perform
their cellular activities would have an ill effect on many aspects of
cellular functioning.
In summary, we have identiﬁed ﬁve proteins that interact
speciﬁcally with HDV RNA: eEF1A1, p54nrb, hnRNP-L, ASF/SF2 and
GAPDH. Similar to what is observed for other RNA viruses, normal
cellular components associated with RNA-processing pathways and
translation machinery appear to be exploited by HDV (Lai, 1998).
Although their precise functions in HDV biology are not fully
understood, their interaction with the HDV RNA genome is consistent
with their known biological properties. Further investigation on the
interactions of these proteins with HDV RNA and on the consequences
of these interactions on the various processes mediated by these
proteinsmight lead to a better comprehension of bothHDV replication
and pathogenicity.
Materials and methods
Synthesis of R199G RNA
The DNA template used for the synthesis of R199G RNA was
generated by PCR off the pHDVd2 plasmid, a derivative of pBlue-scriptKS+ (Stratagene) harboring a dimer of HDV cDNA (Kuo et al.,
1988). The forward primer was designed to contain the T7 promoter
sequence. R199G was synthesized by in vitro transcription using the
T7 RNA polymerase (New England Biolabs; NEB). Transcription
products were subjected to DNAse I (Promega) digestion at 37 °C for
30 min; resolved on denaturing 5% polyacrylamide gel; visualized
under shortwave UV light; excised; eluted in 500 mM ammonium
acetate, 0.1% SDS, 10 mM EDTA; and ethanol-precipitated. The
precipitated RNA was resuspended in 100 μl H2O, passed through a
Sephadex G-50 column (GE Healthcare) and ethanol-precipitated.
RNAwas quantiﬁed by spectrophotometry at a wavelength of 260 nm.
P11.60 RNA was synthesized as previously described (Pelchat and
Perreault, 2004).
Radiolabelling of R199G RNA was carried out as follows. Ten
picomoles of R199G were dephosphorylated using calf intestinal
phosphatase (NEB), 5′-labelled using T4 polynucleotide kinase (NEB)
in the presence of 10 μCi [γ-32P] ATP (GE Healthcare). Radiolabelled
R199G was puriﬁed by phenol/chloroform extraction, passed through
Sephadex G-50 (GE Healthcare), ethanol-precipitated, and resus-
pended in H2O.
UV crosslinking
Radiolabelled R199G (100 fmol) was incubated with 10 μg of HeLa
NE (Accurate Chemical and Scientiﬁc) in 20 mM HEPES pH 7.9,
100 mM KCl, 0.2 mM EDTA, 6.0 mM MgCl2, 0.5 mM DTT and 20%
glycerol, in a ﬁnal volume of 10 μl. P11.60 (50 pmol) or non-
radiolabelled R199G (50 pmol)were added to certain reactions, where
indicated. Reaction mixtures were irradiated for 20 min on ice in UV
Stratalinker 2400 (Stratagene) at a wavelength of 365 nm. Following
addition of 10 μl of 2×SDS loading dye (100 mM Tris–HCl, pH 6.8, 4%
SDS, 0.1% bromophenol blue and 20% glycerol), RNA–protein com-
plexes were resolved on 10% SDS-PAGE and visualized by autoradio-
graphy. To identify the proteins in the complex, the experiment was
repeated, the gel was stained with methylene blue, the resulting
bands were excised and three samples were sent individually to
WEMB Biochem Inc. (Toronto, Canada) for protein analysis by LC-
MSMS, as previously described (Greco-Stewart et al., 2006).
RNA afﬁnity chromatography
Two hundred picomoles of in vitro-synthesized R199G were
oxidized in 20mMTris–HCl (pH 7.5) and 10mMSodium-m-periodate,
precipitated with ethanol, and resuspended in 0.1 M sodium acetate
(pH 5.0). Oxidized RNA was incubated overnight at 4 °C with adipic
acid dihydrazide agarose beads (Sigma), and pre-washed with 0.1 M
sodium acetate (pH 5.0). RNA-coupled beads were then washed 3
times with wash buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA).
Fifty micrograms of HeLa nuclear extract (Accurate Chemical and
Scientiﬁc) were pre-incubated with non-coupled beads partially
equilibrated in binding buffer (10 mM Tris–HCl pH 7.5, 10 mM KCl,
150 mMNaCl, 1 mMMgCl2, 50% glycerol) for 1 h at room temperature,
and centrifuged to remove unbound proteins. The eluted proteins
were added to the RNA-coupled beads and incubated for 1 h at room
temperature. The beads were washed 5 times with binding buffer, and
the bound proteins were eluted following addition of 1×SDS loading
buffer and incubation at 95 °C for 5min. Proteins were resolved on 10%
SDS-PAGE and visualized by silver staining (BioRad). Resulting bands
were excised, subjected to in-gel trypsin digestion and analyzed with
LC-MSMS.
Electrophoretic mobility shift assay
32P-labelled RNA (100 fmol) was mixed with 0.5 μg of puriﬁed,
GST-tagged protein. Reactions were carried out in a ﬁnal volume of
77D. Sikora et al. / Virology 390 (2009) 71–7810 μl containing 20 mM Tris–HCl, pH 7.5, 100 mM KCl, 1 mM EDTA,
1 mM DTT, 0.1 mg/ml BSA, and 20 mMMgCl2. Poly(A) (10 pmol) was
used as a non-speciﬁc competitor. Following a 30-min incubation at
4 °C, 2 μl of agarose loading dye were added, and the samples were
subjected to non-denaturing 5% polyacrylamide gel electrophoresis
(49:1, acrylamide:bis-acrylamide) at 40 V in 1×Tris–Borate–EDTA
(TBE) buffer at room temperature. Bands were visualized by
phosphorimaging.
Co-immunoprecipitation assay
The co-immunoprecipitation experiments were carried out using
the Protein G Immunoprecipitation Kit (Sigma), with a modiﬁed
protocol. Radiolabelled R199G RNA (0.5 pmol) was incubated with
50 μg HeLa nuclear extract (Accurate Chemical and Scientiﬁc) in
1×RIPA buffer (50 mM Tris–HCl, pH 7.5, 1% Nonidet P-40 (NP-40),
0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl) for
30 min at 4 °C. P11.60 RNA (50 pmol) or non-radiolabelled R199G RNA
(50 pmol) were added to certain reactions, where indicated.
Following the 30-min incubation, 5 μg of either anti-eEF1A1 (Abnova),
anti-ASF/SF2 (Zymed), anti-p54nrb (Upstate), anti-hnRNP-L (Abcam),
anti-GAPDH (Santa Cruz), or anti-SMN (BD Transduction Labora-
tories) were added, and the reaction mixtures were incubated for 1 h
at 4 °C before the addition of 30 μl pre-washed protein G agarose
beads. After an overnight incubation at 4 °C, the beads were washed 5
times with 1×RIPA buffer and the RNA was eluted with 40 μl of
acrylamide loading dye. RNA was resolved on denaturing 5%
polyacrylamide gel, and visualized by autoradiography.
Ribonucleoprotein immunoprecipitation assay (RIPA)
The RIP analyses were performed using the method of Niranja-
nakumari et al. (2002) with modiﬁcations described by Greco-
Stewart et al. (2006, 2007). Brieﬂy, HeLa cells were co-transfected
with 10 μg of dimeric HDV genome of positive polarity and 6 μg of
plasmid containing the HDAg-S under control of the high expression
CMV promoter (Lazinski and Taylor, 1993). Approximately 106 cells
were crosslinked by treatment with 1% formaldehyde for 5 min,
collected by centrifugation, washed twice with 1×PBS, and pre-
served at −80 °C prior to analysis.
Cells were resuspended in 2 ml of RIPA buffer (50 mM Tris–Cl, pH
7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycholate, 0.05% SDS,
1 mM EDTA, 150 mM NaCl), disrupted by sonication, and the resulting
lysate was collected by centrifugation at 13,000 rpm. Immunopreci-
pitation reactions were carried out using the Protein G Immunopre-
cipitation Kit (Sigma). The cleared lysate (500 μl) was incubated with
5 μg of each of the following antibodies: goat monoclonal anti-mouse-
IgG (Sigma-Aldrich), anti-eEF1A1 (Abnova), anti-ASF/SF2 (Zymed),
anti-p54nrb (Upstate), anti-hnRNP-L (Abcam), and anti-GAPDH (Santa
Cruz). Pre-washed protein G agarose beads (30 μl) were then added,
and the reactions were incubated overnight at 4 °C. Beads were
washed 5 times with 600 μl of RIPA buffer containing 1 M urea, heated
at 70 °C for 45 min in 50 mM Tris–HCl (pH 7.0), 5 mM EDTA, 10 mM
DTT, and 1% SDS, and eluates were collected by centrifugation. Nucleic
acid was extracted by phenol/chloroform, ethanol-precipitated in the
presence of 100 μg of tRNA, and treated with DNase I (Promega).
Following another phenol/chloroform extraction and ethanol pre-
cipitation, reverse transcription was performed as previously described
(Pelchat et al., 2001) using AMV reverse transcriptase (Promega).
Primers used for the RT reaction were those used to synthesize R199G
cDNA (GGAATTCTAATACGACTCACTATAGGGACTGCTCGAG-
GATCTCTTCTCTCCC and GGAATTCACATCCCCTCTCGGGTGC), and differ-
entiate between the two polarities of the HDV genome. Following the
RT reaction, samples were ampliﬁed by 40 cycles of PCR using Vent
polymerase (New England Biolabs) with an annealing temperature of
50 °C and an extension time of 1 min. Samples were visualized byelectrophoresis on 2% agarose gel in the presence of SYBR green I
(Invitrogen).
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